Non-Proteinuric Diabetic Nephropathy

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, et al. Annual data report. Am J Kidney Dis. 2013;63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001 .

de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA.305(24):2532–9. doi: 10.1001/jama.2011.861 .

Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32(2):64–78.

Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003;348(23):2285–93. doi: 10.1056/NEJMoa021835 .

Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A, et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54(10):2983–7.

de Boer IH, Rue TC, Cleary PA, Lachin JM, Molitch ME, Steffes MW et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med.171(5):412–20. doi: 10.1001/archinternmed.2011.16 .

Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55(6):1832–9.

Dwyer JP, Parving HH, Hunsicker LG, Ravid M, Remuzzi G, Lewis JB. Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Med.2(1):1–10.

Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273–7. doi: 10.1001/jama.289.24.3273 .

Comper WD, Hilliard LM, Nikolic-Paterson DJ, Russo LM. Disease-dependent mechanisms of albuminuria. Am J Physiol Renal Physiol. 2008;295(6):F1589–600. doi: 10.1152/ajprenal.00142.2008 .

Russo LM, Sandoval RM, McKee M, Osicka TM, Collins AB, Brown D, et al. The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int. 2007;71(6):504–13. doi: 10.1038/sj.ki.5002041 .

Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE et al. Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care.34(4):975–81. doi: 10.2337/dc10-1545 .

Boronat M, Garcia-Canton C, Quevedo V, Lorenzo DL, Lopez-Rios L, Batista F et al. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. Ren Fail.36(2):166–70. doi: 10.3109/0886022X.2013.835266 .

Caramori ML, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036–40.

Budhiraja P, Thajudeen B, Popovtzer M. Absence of albuminuria in type 2 diabetics with classical diabetic nephropathy: clinical pathological study. J Biomed Sci Eng. 2013;6(5A):20–5. doi: 10.4236/jbise.2013.65A005 .

Tervaert TW, Mooyaart AL, Amann K, Cohen AH, Cook HT, Drachenberg CB et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol.21(4):556–63. doi: 10.1681/ASN.2010010010 .

Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, Tatsunami S et al. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care.34(3):691–6. doi: 10.2337/dc10-1392

Alter ML, Kretschmer A, Von Websky K, Tsuprykov O, Reichetzeder C, Simon A et al. Early urinary and plasma biomarkers for experimental diabetic nephropathy. Clin Lab.58(7–8):659–71.